ScholarIQanswers from OpenAlex

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations

PaperCitations, authors & open-access status

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations have?

ScholarIQcitation count

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations has 777 citations in the OpenAlex counts ScholarIQ stores.

When was Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations published?

ScholarIQyear

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations has 2022 year in the ScholarIQ index.

What is the open-access status of Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations?

ScholarIQoa status

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations has closed oa status in the ScholarIQ index.

What is the DOI of Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations?

ScholarIQdoi

The DOI for Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations is on the source record.

What is the PMID of Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations?

ScholarIQpmid

The PMID for Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations is on the source record.

What is the OpenAlex record for Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations?

ScholarIQopenalex

The OpenAlex for Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial